Distinguished in Hereditary Angioedema

Avner Reshef

2 Ha'histadrout St, 7830604, 
Ashkelon, D, IL 
Distinguished in Hereditary Angioedema
2 Ha'histadrout St, 7830604, 
Ashkelon, D, IL 
OverviewLocationsClinical Research

Overview

Avner Reshef practices in Ashkelon, Israel. Mr. Reshef is rated as a Distinguished expert by MediFind in the treatment of Hereditary Angioedema. His top areas of expertise are Angioedema, Hereditary Angioedema, Hives, and Hemophilia A.

His clinical research consists of co-authoring 62 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 53 articles and participated in 2 clinical trials in the study of Hereditary Angioedema.

Gender
Male

Locations

2 Ha'histadrout St, 7830604, Ashkelon, D 78306, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Icatibant Outcome Survey (IOS) Registry
Icatibant Outcome Survey (IOS) Registry
Enrollment Status: Completed
Publish Date: October 28, 2024
Open-label, Phase II, Single Arm Study to Evaluate the Safety, Immunogenicity, Pharmacokinetics and Efficacy of rhC1INH for the Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema, From 2-13 Years of Age
Open-label, Phase II, Single Arm Study to Evaluate the Safety, Immunogenicity, Pharmacokinetics and Efficacy of rhC1INH for the Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema, From 2-13 Years of Age
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

62 Total Publications

Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema.
Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema.
Journal: Allergy and asthma proceedings
Published: May 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Reshef's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile